Maryland Capital Management’s Pacira BioSciences PCRX Stock Holding History

Maryland Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$310K	Hold
2022 Q2	$340K	Buy
2022 Q1	$343K	Buy
2021 Q4	$264K	Buy
2021 Q3	$219K	Buy
2021 Q2	$213K	Sell
2021 Q1	$285K	Buy